Site: |
Knight Cancer Institute at Oregon Health Sciences University (OHSU) |
|||
Address: |
3181 S.W. Sam Jackson Park Rd. |
|||
City: |
Portland |
|||
State: |
OR |
|||
Zip: |
97239 |
|||
Country: |
USA |
3 |
Terminated |
Closed |
Imatinib + Bevacizumab |
NCT00324987 |
|
3 |
Terminated |
Closed |
IPI-504 |
NCT00688766 |
|
2 |
Terminated |
Closed |
Olaratumab (IMC-3G3) |
NCT01316263 |
|
Terminated |
Closed |
None |
NCT00640692 |
||
3 |
Recruiting |
Active |
Bezuclastinib plus Sunitinib |
NCT05208047 |
|
1 |
Recruiting |
Active |
IDRX-42 |
NCT05489237 |
|
1 |
Recruiting |
Active |
INBRX-109 + Temozolomide |
NCT03715933 |
|
3 |
Ongoing, but not recruiting |
Closed |
Regorafenib (BAY 73-4506) |
NCT01271712 |
|
1 |
Ongoing, but not recruiting |
Closed |
KTN0158 |
NCT02642016 |
|
2 |
Does not allow GIST |
Closed |
R1507 |
NCT00642941 |
|
2 |
Does not allow GIST |
Active |
IMC-A12 |
NCT00831844 |
|
2 |
Completed |
Closed |
Imatinib |
NCT00237185 |
|
2 |
Completed |
Closed |
STA-9090 |
NCT01039519 |
|
2 |
Completed |
Closed |
Imatinib |
NCT00867113 |
|
2 |
Completed |
Closed |
Imatinib + RAD001 |
NCT01275222 |
|
2 |
Completed |
Closed |
Crenolanib (CP-868,596) |
NCT01243346 |
|
2 |
Completed |
Closed |
Imatinib + AT13387 |
NCT01294202 |
|
2 |
Completed |
Not yet activated |
Linsitinib (OSI-906) |
NCT01560260 |
|
2 |
Completed |
Closed |
Ponatinib (Iclusig) |
NCT01874665 |
|
1 |
Completed |
Closed |
Imatinib + PKC412 |